Accessibility Menu
Wellnex Life Ltd logo

Wellnex Life Ltd(ASX) WNX

Market CapA$3.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-99%
5 YearN/A
1 Year-79%
1 Month+12%
A$0.06
+12.00%
+0.01Today
Wellnex Life Ltd last closing stock price
MetricPriceDate
Last closeAUD 0.062026-07-31
Wellnex Life Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.82%AUD 0.062026-07-23
1 month+12%AUD 0.052026-07-01
3 month-30%AUD 0.082026-05-01
Year to date-40.43%AUD 0.092025-12-31
1 year-78.87%AUD 0.272025-07-31
Since inception-99.1%AUD 6.252017-03-15

Wellnex Life Ltd Financials at a Glance

Market Cap

A$3.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$47.82M

Net Income (TTM)

-A$21.38M

EPS (TTM)

-A$0.28

P/E Ratio

-0.18

Dividend

A$0.00

Beta (Volatility)

0.09 (Low)

Price

A$0.06

Volume

0

Open

A$0.05

Previous Close

A$0.06

Daily Range

A$0.05 - A$0.06

52-Week Range

A$0.04 - A$0.28

Estimated Earnings Date

Aug 28, 2026

WNX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wellnex Life Ltd

Wellnex Life Limited is a health and wellness company that develops, markets, and sells a diverse range of products in Australia, New Zealand, and the United Kingdom. The company focuses on innovative solutions in the health sector, including topical treatments, energy supplements, and over-the-counter medicines.

Products and Services
  • Topical anti-inflammatory creams and sprays under the Pain Away brand
  • Caffeine energy capsules and multivitamins under the Wakey Wakey brand
  • Medicinal cannabis products marketed under the Wellness Life brand
Growth Outlook
  • Recent quarterly revenue reached AUD 12.9 million, indicating strong market demand
  • Expansion into the UK market is expected to drive future growth
  • Continued investment in product development aims to enhance competitive positioning
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 41.5 million reflects a growing customer base
  • Recent quarterly gross profit margin improved to 13.7%, showcasing operational efficiency
  • Cash and cash equivalents increased to AUD 975,000, providing liquidity for operations
Wellnex Life Limited operates in the consumer defensive sector, focusing on health and wellness products. The company has shown resilience in its revenue generation, with a notable increase in quarterly revenue, reflecting a positive market response to its product offerings. The strategic expansion into new markets, particularly the UK, is anticipated to further enhance growth prospects. Financially, the company has demonstrated improvements in gross profit margins, indicating effective cost management and operational efficiency. The increase in cash reserves also positions the company favorably for future investments and operational needs. Overall, Wellnex Life Limited presents a compelling opportunity for investors interested in the health and wellness sector.
AI Generated • Jul 24, 2026

Industry

Food Products

CEO

Zack Bozinovski; George Karafotias

Headquarters

Port Melbourne, VIC 3207, AU

WNX Financials

Key Financial Metrics (TTM)

Gross Margin

24.08%

Operating Margin

-20.78%

Net Income Margin

-40.16%

Return on Equity

-92.72%

Return on Capital

-39.66%

Return on Assets

-35.47%

Earnings Yield

-5.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$3.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

73.03M

Volume

0

Avg. Volume

56.28K

Financials (TTM)

Gross Profit

A$12.10M

Operating Income

-A$7.92M

EBITDA

-A$10.29M

Operating Cash Flow

-A$5.31M

Capital Expenditure

A$3.00M

Free Cash Flow

-A$2.31M

Cash & ST Invst.

A$975.00K

Total Debt

A$10.03M

Wellnex Life Ltd Performance Analysis

Wellnex Life Ltd annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 18,607,000N/A
20232023-06-30AUD 27,876,00049.8%
20242024-06-30AUD 16,932,000-39.3%
20252025-06-30AUD 23,625,00039.5%
Wellnex Life Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3099.5%
Q22024-12-316.1%
Q42025-06-30-2.5%
Q22025-12-3110.8%
Wellnex Life Ltd annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.85N/A
20232023-06-30AUD -1.1940.5%
20242024-06-30AUD -0.73-38.6%
20252025-06-30AUD -0.53-27.2%
Wellnex Life Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3060.3%
Q22024-12-31-91.3%
Q42025-06-3043.2%
Q22025-12-3189.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$12.92M

+128.5%

Gross Profit

A$1.77M

+173.4%

Gross Margin

13.67%

N/A

Market Cap

A$3.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.22M

N/A

Employees

3

N/A

Net Income

-A$1.79M

+81.6%

EBITDA

-A$302.00K

+95.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$975.00K

+263.8%

Total Debt

A$10.03M

+25.2%

Accounts Receivable

A$4.03M

+38.6%

Inventory

A$2.92M

-41.0%

Long Term Debt

A$4.82M

-15.8%

Short Term Debt

A$5.22M

+127.8%

Return on Assets

-35.47%

N/A

Return on Invested Capital

-34.21%

N/A

Free Cash Flow

-A$3.14M

+17.7%

Operating Cash Flow

-A$3.14M

+17.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVE.AXEVE Health Group Limited
A$0.01-12.50%
CCO.AXThe Calmer Co International Limited
A$0.00+0.00%
8IH.AX8I Holdings Limited
A$0.01+0.00%
PFT.AXPure Foods Tasmania Limited
A$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$160.94+0.28%
AMIXAutonomix Medical
$10.55+1.89%
NOKNokia
$9.99+0.07%
INTCIntel
$100.17+0.10%

Questions About WNX

What is the current price of Wellnex Life Ltd?

Wellnex Life Ltd is trading at A$0.06 per share.

What is the 52-week range for Wellnex Life Ltd?

Over the past 52 weeks, Wellnex Life Ltd has traded between A$0.04 and A$0.28.

How much debt does Wellnex Life Ltd have?

As of the most recent reporting period, Wellnex Life Ltd reported total debt of A$5.71M.

How much cash does Wellnex Life Ltd have on hand?

Wellnex Life Ltd reported A$497.00K in cash and cash equivalents in its most recent financial results.

What is Wellnex Life Ltd’s dividend yield?

Wellnex Life Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.